JP2023541522A5 - - Google Patents
Info
- Publication number
- JP2023541522A5 JP2023541522A5 JP2023507550A JP2023507550A JP2023541522A5 JP 2023541522 A5 JP2023541522 A5 JP 2023541522A5 JP 2023507550 A JP2023507550 A JP 2023507550A JP 2023507550 A JP2023507550 A JP 2023507550A JP 2023541522 A5 JP2023541522 A5 JP 2023541522A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- membered
- compound
- unsubstituted
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL2020000066 | 2020-08-03 | ||
| PLPCT/PL2020/000066 | 2020-08-03 | ||
| PCT/EP2021/071694 WO2022029138A1 (en) | 2020-08-03 | 2021-08-03 | Low molecular weight protein degraders and their applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023541522A JP2023541522A (ja) | 2023-10-03 |
| JP2023541522A5 true JP2023541522A5 (https=) | 2024-07-25 |
Family
ID=72193535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507550A Pending JP2023541522A (ja) | 2020-08-03 | 2021-08-03 | 低分子量タンパク質分解物質及びその適用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240294489A1 (https=) |
| EP (1) | EP4188373A1 (https=) |
| JP (1) | JP2023541522A (https=) |
| KR (1) | KR20230048373A (https=) |
| CN (1) | CN116457344A (https=) |
| AU (1) | AU2021319847A1 (https=) |
| BR (1) | BR112023001956A2 (https=) |
| CA (1) | CA3186919A1 (https=) |
| IL (1) | IL300308A (https=) |
| MX (1) | MX2023001401A (https=) |
| WO (1) | WO2022029138A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240368113A1 (en) * | 2021-06-28 | 2024-11-07 | Chengdu Fendi Pharmaceutical Co. Ltd. | Amide compound and use thereof |
| CN116082301A (zh) * | 2021-11-05 | 2023-05-09 | 上海美志医药科技有限公司 | 具有降解gspt1活性的化合物及其应用 |
| JP2024544507A (ja) * | 2021-11-09 | 2024-12-03 | コリア リサーチ インスティテュート オブ ケミカル テクノロジー | グルタルイミド母核を有するイソインドリノン誘導体及びその用途 |
| EP4446324A4 (en) * | 2021-12-08 | 2026-05-06 | Gluetacs Therapeutics Shanghai Co Ltd | Ligand compounds for e3 ubiquitin ligase, protein degraders developed on basis of ligand compounds, and uses thereof |
| US12122764B2 (en) | 2021-12-22 | 2024-10-22 | Gilead Sciences, Inc. | IKAROS zinc finger family degraders and uses thereof |
| KR20240123836A (ko) * | 2021-12-22 | 2024-08-14 | 길리애드 사이언시즈, 인코포레이티드 | 이카로스 아연 핑거 패밀리 분해제 및 이의 용도 |
| WO2023178181A1 (en) | 2022-03-17 | 2023-09-21 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
| CN114835680A (zh) * | 2022-04-29 | 2022-08-02 | 成都分迪药业有限公司 | 卤素取代异吲哚啉化合物及其应用 |
| CN115636811A (zh) * | 2022-08-17 | 2023-01-24 | 成都分迪药业有限公司 | 异吲哚啉苄胺衍生物的合成方法 |
| EP4584259A1 (en) | 2022-09-09 | 2025-07-16 | Innovo Therapeutics, Inc. | Ck1alpha and dual ck1alpha / gspt1 degrading compounds |
| WO2024096753A1 (en) | 2022-11-02 | 2024-05-10 | Captor Therapeutics S.A. | Nek7 degraders and methods of use thereof |
| WO2025179161A1 (en) | 2024-02-21 | 2025-08-28 | Innovo Therapeutics, Inc. | Protein degrading compounds |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635517B1 (en) | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
| US6306663B1 (en) | 1999-02-12 | 2001-10-23 | Proteinex, Inc. | Controlling protein levels in eucaryotic organisms |
| US7323479B2 (en) | 2002-05-17 | 2008-01-29 | Celgene Corporation | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| US8877780B2 (en) * | 2006-08-30 | 2014-11-04 | Celgene Corporation | 5-substituted isoindoline compounds |
| CL2007002513A1 (es) * | 2006-08-30 | 2008-04-04 | Celgene Corp Soc Organizada Ba | Compuestos derivados de isoindolina sustituidos, compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento y prevencion de enfermedades tales como cancer, dolor, degeneracion macular, entre otras. |
| ME02420B (me) | 2006-09-26 | 2016-09-20 | Celgene Corp | 5-supstituirani derivati kinazolinona kao sredstva protiv raka |
| PL3202460T3 (pl) | 2010-02-11 | 2019-12-31 | Celgene Corporation | Pochodne arylometoksyizoindoliny i zawierające je kompozycje oraz sposoby ich zastosowania |
| US9499514B2 (en) * | 2014-07-11 | 2016-11-22 | Celgene Corporation | Antiproliferative compounds and methods of use thereof |
| EP3454856B1 (en) * | 2016-05-10 | 2024-09-11 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
| CN109790143A (zh) | 2016-05-10 | 2019-05-21 | C4医药公司 | 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体 |
| WO2017197056A1 (en) * | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Bromodomain targeting degronimers for target protein degradation |
| IL312367A (en) * | 2017-01-31 | 2024-06-01 | Arvinas Operations Inc | Cereblon ligands and bifunctional compounds comprising the same |
| US10406165B2 (en) * | 2017-03-14 | 2019-09-10 | Biotheryx, Inc. | Compounds targeting proteins, compositions, methods, and uses thereof |
| CN110769822A (zh) | 2017-06-20 | 2020-02-07 | C4医药公司 | 用于蛋白降解的n/o-连接的降解决定子和降解决定子体 |
| EP4467143B1 (en) | 2017-07-10 | 2026-03-11 | Celgene Corporation | Method for preparing 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-l-yl)-3-fluorobenzonitrile |
| TWI793151B (zh) * | 2017-08-23 | 2023-02-21 | 瑞士商諾華公司 | 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途 |
| CA3075813A1 (en) * | 2017-10-04 | 2019-04-11 | Dana-Farber Cancer Institute, Inc. | Small molecule inhibition of transcription factor sall4 and uses thereof |
| CA3101338A1 (en) * | 2018-06-13 | 2019-12-19 | Biotheryx, Inc. | Aminoamide compounds |
| CN113347974A (zh) * | 2018-12-31 | 2021-09-03 | 细胞基因公司 | 2-(4-氯苯基)-n-((2-(2,6-二氧代哌啶-3-基)-1-氧代异吲哚啉-5-基)甲基)-2,2-二氟乙酰胺的组合物和使用方法 |
-
2021
- 2021-08-03 US US18/040,383 patent/US20240294489A1/en active Pending
- 2021-08-03 EP EP21758624.7A patent/EP4188373A1/en active Pending
- 2021-08-03 MX MX2023001401A patent/MX2023001401A/es unknown
- 2021-08-03 IL IL300308A patent/IL300308A/en unknown
- 2021-08-03 KR KR1020237007785A patent/KR20230048373A/ko active Pending
- 2021-08-03 JP JP2023507550A patent/JP2023541522A/ja active Pending
- 2021-08-03 CN CN202180067832.3A patent/CN116457344A/zh active Pending
- 2021-08-03 AU AU2021319847A patent/AU2021319847A1/en active Pending
- 2021-08-03 WO PCT/EP2021/071694 patent/WO2022029138A1/en not_active Ceased
- 2021-08-03 BR BR112023001956A patent/BR112023001956A2/pt unknown
- 2021-08-03 CA CA3186919A patent/CA3186919A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023541522A5 (https=) | ||
| CN109789146B (zh) | 趋化因子受体调节剂及其用途 | |
| US20240294489A1 (en) | Low molecular weight protein degraders and their applications | |
| JP2017533922A5 (https=) | ||
| JP2006515587A (ja) | 性的不能を治療する方法 | |
| CN102083773A (zh) | {f-19}标记的l-谷氨酸和l-谷氨酰胺衍生物(ⅲ)、其用途和制备方法 | |
| CN110248662A (zh) | 一种治疗前列腺癌的组合、药物组合物及治疗方法 | |
| EP3784662B1 (fr) | Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices | |
| JP2019509986A (ja) | トリプトライドのグルコース・コンジュゲート、その類縁体及び使用 | |
| JP2007505044A5 (https=) | ||
| US10077236B2 (en) | Azacyclic constrained analogs of FTY720 | |
| JP2022169780A5 (https=) | ||
| WO2018068665A1 (zh) | 微管蛋白抑制剂 | |
| BR112012020377B1 (pt) | Uso de um composto ou sal farmaceuticamente aceitável do mesmo e embalagem comercial | |
| AU2021328979A1 (en) | Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof | |
| WO2013075199A1 (pt) | "compostos acil-hidrazonas e oxadiazóis, composições farmacêuticas compreendendo os mesmos e seus usos | |
| RU2004111787A (ru) | Ретиноидные агонисты (1), производные алкилмочевины | |
| BRPI0906248B1 (pt) | composto, composição farmacêutica para inibir a formação de microtúbulos e método para preparar um composto | |
| JP2023550035A (ja) | がん治療におけるｍｅｔａｐ２阻害剤及びｃｄｋ４／６阻害剤の組み合わせ | |
| CN108473449B (zh) | 一种作为吲哚胺-2,3-双加氧酶抑制剂的砜脒及其制备方法和用途 | |
| AU2017355566A1 (en) | Inhibitors of mtor-deptor interactions and methods of use thereof | |
| US10093609B2 (en) | TAK1 kinase inhibitors, compositions, and uses related thereto | |
| WO2023224128A1 (ja) | 線維症の治療又は予防のための医薬組成物 | |
| RU2004111789A (ru) | Ретиноидные агонисты | |
| RU2800042C1 (ru) | Спиросоединения в качестве ингибиторов ERK и их применение |